Belite Bio Inc

NASDAQ: BLTE · Real-Time Price · USD
65.20
1.78 (2.81%)
At close: Aug 21, 2025, 3:59 PM
65.20
0.00%
After-hours: Aug 21, 2025, 04:10 PM EDT

Belite Bio Inc Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 May 31, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-17.6M -15.52M -11.46M -9.74M -10.47M -8.33M -6.96M -10.96M -6.87M -6.88M -6.72M -2.54M -2.51M -1.05M -2.5M -2.5M -2.4M -2.4M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 3.50 3.50 n/a n/a n/a n/a n/a n/a
Pretax Income
-16.32M -14.28M -10.1M -8.68M -9.49M -7.87M -6.99M -10.93M -6.81M -6.89M -6.78M -2.4M -2.39M -1.07M -2.47M -2.47M -2.36M -2.36M
Net Income
-16.32M -14.28M -10.1M -8.68M -9.49M -7.87M -6.99M -10.94M -6.81M -6.89M -6.78M -2.4M -2.28M -1.09M -2.47M -2.47M -2.36M -2.36M
Selling & General & Admin
6.55M 6.12M 4.2M 2.9M 1.39M 1.56M 2.09M 2.22M 1.35M 1.16M 1.5M 1.35M 927K 175K 610K 610K 579K 579K
Research & Development
11.05M 9.4M 7.25M 6.84M 9.08M 6.76M 4.86M 8.74M 5.52M 5.72M 5.23M 1.19M 1.58M 878K 1.89M 1.89M 1.82M 1.82M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a 62K -8K n/a n/a n/a n/a 31.5K n/a 31.5K 31.5K
Operating Expenses
17.6M 15.52M 11.46M 9.74M 10.47M 8.33M 6.96M 10.96M 6.87M 6.88M 6.72M 2.54M 2.51M 1.05M 2.47M 2.48M 2.36M 2.36M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a 8K 32.75K n/a n/a 17K 500.00 n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
17.6M 15.52M 11.46M 9.74M 10.47M 8.33M 6.96M 10.96M 6.87M 6.88M 6.72M 2.54M 2.51M 1.05M 2.47M 2.48M 2.36M 2.36M
Income Tax Expense
n/a n/a n/a n/a n/a 6K -1K 1K 3K 6K 32.75K -7.5 -115K 17K n/a n/a n/a n/a
Shares Outstanding (Basic)
32.59M 32.08M 31.45M 30.69M 30.32M 29.68M 28.32M 27.32M 25.79M 20.95M 22.42M 24.87M 19.66M 24.1M 9.57M 9.57M 9.57M 9.57M
Shares Outstanding (Diluted)
32.59M 32.08M 31.45M 30.69M 30.32M 29.68M 28.32M 27.32M 25.79M 20.95M 22.42M 24.87M 19.66M 24.1M 9.57M 9.57M 9.57M 9.57M
EPS (Basic)
-0.5 -0.44 -0.32 -0.28 -0.31 -0.27 -0.25 -0.4 -0.26 -0.33 -0.3 -0.1 -0.12 -0.05 -0.26 -0.26 -0.25 -0.25
EPS (Diluted)
-0.5 -0.44 -0.32 -0.28 -0.31 -0.27 -0.25 -0.4 -0.26 -0.33 -0.3 -0.1 -0.12 -0.05 -0.26 -0.26 -0.25 -0.25
EBITDA
-16.32M -15.52M -11.41M -9.74M -10.44M -8.29M -6.86M -10.95M -6.86M -6.87M -6.71M -2.53M -2.5M -1.05M -2.49M -2.49M -2.39M -2.39M
EBIT
-16.32M -15.52M -7.58M -9.74M -10.47M -8.33M -6.96M -10.96M -6.87M -6.88M -6.53M -2.54M -2.51M -1.05M -2.5M -2.5M -2.4M -2.4M
Depreciation & Amortization
n/a 42K 42K 34.75K 34.75K 34.75K 91K 16K 16K 16K 16K 7.5K 7.5K 7.5K 7.5K 7.5K 7.5K 7.5K